Trial intelligence / Profile preview

TRUS Guided Betamethasone for Chronic Non-Bacterial Prostatitis

NCT04210739Phase 1Unknown

Sponsor
Cairo University
Start
Jul 2020
Primary completion
Jul 2021
Modality
Orthosteric Ligands
01

Overview

Phase 1, open-label, single-arm trial of betamethasone sodium in Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), sponsored by Cairo University. Primary endpoint: International Prostate Symptom Score at 3 months. Status: unknown.

02

Drugs

betamethasone sodium
03

Conditions

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)

Beyond the preview

Go deeper on NCT04210739.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04210739.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call